Formulation of inactivated influenza vaccines for providing effective cross-protection by intranasal vaccination in mice
- 31 December 1994
- Vol. 12 (4) , 310-316
- https://doi.org/10.1016/0264-410x(94)90094-9
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Cross‐protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin moleculesEuropean Journal of Immunology, 1991
- Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenzaVaccine, 1990
- Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunitVaccine, 1988
- Sequence Analysis of the Haemagglutinin of A/Taiwan/1/86, a New Variant of Human Influenza A(H1N1) VirusJournal of General Virology, 1987
- Cross‐protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivityEuropean Journal of Immunology, 1984
- Nucleotide sequence of the haemagglutinin gene of a human influenza virus H1 subtypeNature, 1981
- Actions of cholera toxin and the prevention and treatment of choleraNature, 1981
- ASSESSMENT OF INACTIVATED INFLUENZA-A VACCINE AFTER THREE OUTBREAKS OF INFLUENZA A AT CHRIST'S HOSPITALThe Lancet, 1979
- ANTIBODY RESPONSES TO ANTIGENIC DETERMINANTS OF INFLUENZA VIRUS HEMAGGLUTININThe Journal of Experimental Medicine, 1974
- DISQUISITIONS ON ORIGINAL ANTIGENIC SINThe Journal of Experimental Medicine, 1966